IQVIA Holdings

Latest news

• IQVIA Korea revenue nearly triples in decade as clinical research, data biz expands (opens in a new tab)

  Korea Biomedical Review · Oct 2, 2026

• Judge 'Flummoxed' By Forum Claim In IQVIA's Poaching Suit (opens in a new tab)

  Law360 · Oct 2, 2026

• A Look at IQVIA Holdings Inc (IQV) After 3.0% Decline -- GF Value $249.48 vs Price $260.72 (opens in a new tab)

  GuruFocus · Oct 1, 2026

• IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors (opens in a new tab)

  MarketWatch · Oct 1, 2026

• Iqvia acquires patient engagement company Reverba (opens in a new tab)

  Axios · Oct 1, 2026

• UBS resumes coverage of IQVIA Holdings stock with USD 345.00 target (opens in a new tab)

  AD HOC NEWS · Oct 1, 2026

• IQVIA Sees 'Meaningful' Tailwind From Accelerating New Drug Approvals, RBC Capital Markets Says (opens in a new tab)

  Moomoo · Sep 30, 2026

• IQVIA Holdings Price Target Announced at $345.00/Share by UBS (opens in a new tab)

  Moomoo · Sep 30, 2026

• UBS Adjusts IQVIA Price Target to $345 From $240, Maintains Buy Rating (opens in a new tab)

  Yahoo Finance · Sep 30, 2026

• UBS resumes IQVIA stock coverage with buy rating on bookings outlook (opens in a new tab)

  Investing.com · Sep 30, 2026

• Iqvia resumed with a Buy at UBS (opens in a new tab)

  TipRanks · Sep 30, 2026

• IQVIA Holdings Q3FY26 Results: Earnings call scheduled for Oct 27 (opens in a new tab)

  scanx.trade · Sep 30, 2026

• Is IQVIA Holdings (IQV) Reasonable After A 42% 1 Year Run? (opens in a new tab)

  Simply Wall Street · Sep 30, 2026

• IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026 (opens in a new tab)

  FinancialContent · Sep 29, 2026

• IQVIA Holdings, Inc. (IQV) Stock Forecasts (opens in a new tab)

  Yahoo Finance · Sep 29, 2026

• Iqvia price target raised to $319 from $247 at RBC Capital (opens in a new tab)

  TipRanks · Sep 29, 2026

• RBC Capital raises IQVIA stock price target on drug approvals By Investing.com (opens in a new tab)

  Investing.com Nigeria · Sep 29, 2026

• RBC Capital raises IQVIA stock price target on drug approvals (opens in a new tab)

  Investing.com · Sep 29, 2026

• IQVIA Holdings stock trades at EUR 239.40 with plus 0.02 percent (opens in a new tab)

  AD HOC NEWS · Sep 29, 2026

• RBC Capital maintains Outperform rating on IQVIA Holdings, $319 price target (opens in a new tab)

  TradingView · Sep 29, 2026

• Analysts Offer Insights on Healthcare Companies: Xencor (XNCR) and IQVIA Holdings (IQV) (opens in a new tab)

  The Globe and Mail · Sep 29, 2026

• RBC Raises Price Target on IQVIA Holdings to $319 From $247, Keeps Outperform Rating (opens in a new tab)

  marketscreener.com · Sep 29, 2026

• Baird Adjusts Price Target on IQVIA to $324 From $287, Keeps Outperform Rating (opens in a new tab)

  Yahoo Finance · Sep 29, 2026

• Truist Raises Price Target on IQVIA Holdings to $329 From $300, Keeps Buy Rating (opens in a new tab)

  Moomoo · Sep 28, 2026

• IQVIA Holdings stock trades near its yearly high after HSBC target rise (opens in a new tab)

  AD HOC NEWS · Sep 28, 2026

• Truist Securities reiterates Buy rating on IQVIA Holdings, $329 price target (opens in a new tab)

  TradingView · Sep 28, 2026

• Truist raises IQVIA stock price target on healthy demand outlook By Investing.com (opens in a new tab)

  Investing.com Nigeria · Sep 28, 2026

• Truist raises IQVIA stock price target on healthy demand outlook (opens in a new tab)

  Investing.com · Sep 28, 2026

• IQVIA stock at USD 270.37 on September 25, 2026, down 1.69 percent (opens in a new tab)

  AD HOC NEWS · Sep 28, 2026

• IQVIA Holdings (IQV) Looks Fairly Valued As AI And Data Momentum Builds (opens in a new tab)

  Simply Wall Street · Sep 26, 2026